AMD: Analysts Call For Q2 Revenues Of $6.55 Billion

Advanced Micro Devices (NASDAQ: AMD) will be reporting its second quarter financial results today after market close. Analysts have a consensus $128.11 12-month price target on the company, via a total of 42 analysts, with nine analysts having strong buy ratings.

19 analysts meanwhile have buy ratings, 13 analysts have hold ratings and a single analyst has a sell rating on the stock. The street high comes from Elazar Advisors with a $230 price target, and the lowest target sits at $85.

26 analysts have revenue estimates for the second quarter. The mean revenue estimate between all 26 analysts is $6.55 billion; this number has been revised upwards since the start of the year. The highest revenue estimate is $6.7 billion, while the lowest is $6.5 billion.

Onto EBITDA estimates, there are currently only 4 analysts who have second-quarter EBITDA estimates. The mean is currently $2.1 billion. The estimate has been revised lower since the start of the year. Street high is a $2.1 billion EBITDA estimate, and the lowest is $2 billion.

Analysts estimate that quarterly earnings per share will come in at $1.03, up from the $0.78 estimate at the start of the year. The street high estimate is $1.16, and the lowest estimate is $0.97 per share for the quarter.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to the organizations discussed. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Canada Should Be as Rich as Saudi Arabia. But It’s Not! | Michael Gentile

Artemis Gold Q3 Earnings: Growth Already In Focus

IAMGOLD Q3 Earnings: Market Responds With MASSIVE Price Lift

Recommended

Kalshi Faces Class Action Lawsuit Over Alleged Illegal Sports Betting

Silver47 Hits 606 g/t Over 9.7 Metres Silver Equivalent In Final Assays From 2025 Drill Program At Red Mountain

Related News

CloudMD: Canaccord Raises Price Target To $3.75

Wednesday morning, it was announced that CloudMD Software & Services (TSXV: DOC) is acquiring VisionPros,...

Friday, February 19, 2021, 04:01:00 PM

Canaccord Initiates Coverage On Uranium Royalty Corp With $1.60 Price Target

This morning Canaccord Genuity’s Katie Lachapelle initiated coverage on Uranium Royalty Corp (TSXV: URC) with...

Tuesday, September 8, 2020, 03:17:18 PM

Harvest Health: Canaccord Reiterates Price Target Following Earnings

On August 10, Harvest Health and Recreation (CSE: HARV) reported its second quarter results. The...

Thursday, August 12, 2021, 03:49:00 PM

PI Financial Discontinues Coverage On Medipharm Labs, Heritage Cannabis

Friday evening following the close of markets, a note was sent out by PI Financials...

Monday, September 28, 2020, 07:42:00 AM

Tilray: Canaccord Reiterates US$12 Price Target After Distillery Purchase

On December 8th, Tilray (TSX: TLRY) announced the acquisition of Breckenridge Distillery, a whiskey and...

Friday, December 10, 2021, 03:39:00 PM